We are live on ! Find out more
HQL

abrdn Life Sciences Investors

83 hedge funds and large institutions have $142M invested in abrdn Life Sciences Investors in 2025 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 6

74% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 19

21% more capital invested

Capital invested by funds: $118M → $142M (+$24.1M)

11% more funds holding

Funds holding: 7583 (+8)

0.09% less ownership

Funds ownership: 31.77%31.69% (-0.09%)

Holders
83
Holders Change
+8
Holders Change %
+10.67%
% of All Funds
1.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
33
Reduced
19
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MG
26
Marex Group
$884K +$780K +56,967 New
First Trust Advisors
27
First Trust Advisors
Illinois
$727K +$158K +11,569 +33%
UBS Group
28
UBS Group
Switzerland
$571K -$72.5K -5,298 -13%
KWM
29
Kingsview Wealth Management
Oregon
$556K -$11.9K -869 -2%
Commonwealth Equity Services
30
Commonwealth Equity Services
Massachusetts
$512K -$2.35K -172 -0.5%
Osaic Holdings
31
Osaic Holdings
Arizona
$480K +$35K +2,556 +8%
NA
32
NewEdge Advisors
Louisiana
$417K -$100K -7,308 -21%
GC
33
Guggenheim Capital
Illinois
$411K -$17.8K -1,298 -5%
WAM
34
WNY Asset Management
New York
$399K +$10.3K +749 +3%
SI
35
Stephens Inc
Arkansas
$370K +$36.1K +2,638 +12%
KAS
36
KPP Advisory Services
Kentucky
$360K -$4.35K -318 -1%
PFO
37
PMG Family Office
Texas
$351K +$310K +22,636 New
SPIA
38
Steward Partners Investment Advisory
New York
$332K +$112K +8,208 +62%
Stifel Financial
39
Stifel Financial
Missouri
$329K +$3.42K +250 +1%
SIC
40
Samalin Investment Counsel
New York
$288K -$44.3K -3,236 -15%
Balyasny Asset Management
41
Balyasny Asset Management
Illinois
$284K +$251K +18,340 New
AUB
42
Atlantic Union Bankshares
Virginia
$276K
SWP
43
Stratos Wealth Partners
Ohio
$235K +$6.37K +465 +3%
KFA
44
Kapstone Financial Advisors
Ohio
$217K -$68 -5 -0%
Jane Street
45
Jane Street
New York
$217K +$191K +13,971 New
IFG
46
Independent Financial Group
California
$206K +$1.78K +130 +1%
LOPW
47
Live Oak Private Wealth
North Carolina
$205K
Cambridge Investment Research Advisors
48
Cambridge Investment Research Advisors
Iowa
$196K +$24.9K +1,818 +17%
CA
49
Cornerstone Advisors
North Carolina
$175K +$155K +11,300 New
WS
50
Wedbush Securities
California
$170K -$13.7K -1,000 -8%

HQL Hedge Fund Activity: Q3 2025 in Review

83 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2025, worth a combined $142M — up 21% from $118M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new HQL positions and 6 closed out — a net gain of 9 holders — while 33 added to existing stakes and 19 trimmed.

The largest buyer was Shaker Financial Services, adding an estimated $2.28M. The largest seller was Saba Capital Management, cutting an estimated $5.9M.

  • 83 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2025, up from 75 in Q2 2025.
  • Funds reported $142M of abrdn Life Sciences Investors stock for Q3 2025, up 21% quarter-over-quarter.
  • 15 funds opened new abrdn Life Sciences Investors positions in Q3 2025 and 6 closed out, a net change of +9 holders.
  • The largest abrdn Life Sciences Investors buyer in Q3 2025 was Shaker Financial Services, an estimated $2.28M added.
  • The largest abrdn Life Sciences Investors seller in Q3 2025 was Saba Capital Management, an estimated $5.9M sold.

Based on aggregated 13F filings for Q3 2025.